However, the molecular mechanisms underlying CARM1 regulation of estrogen/ER-mediated gene transcriptional activation remain incompletely understood, which is partially due to lack of genome- and proteome-wide study to systematically reveal their genomic binding sites, transcriptional targets and cancer-relevant substrates. This evidence concerns the gene CARM1 and cancer.